Kristell S. Chatalic
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments.
Journal: Journal of personalized medicine
Published: March 16, 2021
213Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer Xenografts.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: March 17, 2017
Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent.
Journal: Theranostics
Published: December 18, 2015
In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies.
Journal: Theranostics
Published: August 17, 2015
Radiopeptides for Imaging and Therapy: A Radiant Future.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 07, 2015
A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 27, 2015
Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 22, 2014
Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists.
Journal: European journal of medicinal chemistry
Published: December 27, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026